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ABSTRACT
Prostate cancer is one of the most common forms of cancer and the third leading cause of cancer death in North
America. As an integrated part of computer-aided detection (CAD) tools, diffusion-weighted magnetic resonance
imaging (DWI) has been intensively studied for accurate detection of prostate cancer. With deep convolutional
neural networks (CNNs) significant success in computer vision tasks such as object detection and segmentation,
different CNNs architectures are increasingly investigated in medical imaging research community as promising
solutions for designing more accurate CAD tools for cancer detection. In this work, we developed and implemented
an automated CNNs-based pipeline for detection of clinically significant prostate cancer (PCa) for a given axial
DWI image and for each patient. DWI images of 427 patients were used as the dataset, which contained 175
patients with PCa and 252 healthy patients. To measure the performance of the proposed pipeline, a test set of
108 (out of 427) patients were set aside and not used in the training phase. The proposed pipeline achieved area
under the receiver operating characteristic curve (AUC) of 0.87 (95% Confidence Interval (CI): 0.84−0.90) and
0.84 (95% CI: 0.76−0.91) at slice level and patient level, respectively.
Introduction
Prostate cancer is the most common form of cancer among males in the United States. In 2017, it was the third
leading cause of death from cancer in men in the United States, with around 161,360 new cases which represented
19% of all new cancer cases and 26,730 deaths, which represented 8% of all cancer deaths1. Despite the fact that
prostate cancer is the most common form of cancer, if detected in the early stages, the survival rates are high due
to slow progression of the disease1. Therefore, effective monitoring and early detection are the key for improved
patients’ survival.
Currently, accepted clinical methods to diagnose clinically significant prostate cancer (PCa) are a combination
of the prostate-specific antigen (PSA) test, digital rectal exam (DRE), trans-rectal ultrasound (TRUS), and magnetic
resonance imaging (MRI). However, PSA screening leads to over-diagnosis, which leads to unnecessary expensive
and painful needle biopsies and potential over-treatment2. Multiparametric MRI which relies heavily on diffusion-
weighted imaging (DWI) has been increasingly becoming the standard of care for prostate cancer diagnosis in
radiology setting where the area under the receiver operating characteristic curve (ROC) varies from 0.69 to 0.81 for
radiologists detecting PCa3. A standardized approach to image interpretation called Pi-Rads v24 has been developed
for radiologists, however, there remain issues with inter-observer variability in the use of the Pi-Rads scheme5.
Machine learning (ML) is a branch of artificial intelligence (AI) that is based on the idea of the system learning a
pattern from a large scale database by using probabilistic and statistical tools and making decisions or predictions on
the new data6–8. In medical imaging field, computer-aided detection and diagnosis (CAD), which is a combination
of imaging feature engineering and ML classification, has shown potential in assisting radiologists for accurate
diagnosis, decreasing the diagnosis time and the cost of diagnosis. Traditional feature engineering methods are
based on extracting quantitative imaging features such as texture, shape, volume, intensity, and various statistics
features from imaging data followed by a ML classifier such as Support Vector Machines (SVM), Adaboost, and
Decision Trees9–14.
Deep learning methods have shown promising results in a variety of computer vision tasks such as segmentation,
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classification, and object-detection15–17. These methods consist of convolutional layers that are able to extract
different features from low-level local features to high-level global features from input images. A fully connected
layer at the end of the convolutional neural layers converts convoluted features into the probabilities of certain
labels15. Different types of layers, such as batch normalization layer18, which normalizes the input of a layer with a
zero mean and a unit variant, and dropout layer19, which is one of regularization techniques that ignores randomly
selected nodes, have been shown to improve the performance of deep learning-based methods. Nevertheless, to
achieve convincing performance, an optimal combinations and structures of the layers as well as precise fine-tuning
of hyper-parameters are required15, 17, 20. This remains as one of the main challenges of deep learning-based methods
when applied to different fields such as medical imaging.
With CNNs’ promising results in computer vision field15, 21, the medical imaging research community has shifted
their interest toward deep learning-based methods for designing CAD tools for cancer detection. As a widely used
approach, most of proposed algorithms require user-drawn regions of interest (ROI) to classify these user-annotated
ROIs to PCa lesions and non PCa lesions. Tsehay et al.22 conducted a 3 × 3 pixel level analysis by 5 convolution
layers deep VGGNet20 inspired CNNs with 196 patients. They fine-tuned their classifier by cross-validation method
within the training set with 144 patients and achieved area under ROC curve (AUC) of 0.90 AUC on a separated test
set of 52 patients. The result was based on 3 × 3 windows of pixels extracted from MRI slices of DWI, T2-weighted
images (T2w), and b-value images of 2000s mm−2.
Le et al.23 conducted two dimensional (2D) ROI classification with combination of fused multimodal Residual
Network (ResNet)17 and the traditional handcrafted feature extraction method. They augmented the training dataset
and used the test set for fine-tuning and evaluating their classifier. They achieved ROI-level (lesion-level) AUC of
0.91. Liu et al.24 used VGGNet inspired 2D CNNs classifier to classify each sample corresponding to a 32 × 32
ROI (lesion) centered around biopsy location using a dataset, which was part of ProstateX challenge competition
(“SPIE-AAPM-NCI Prostate MR Classification Challenge”)25. They separated the dataset, 341 patients, into 3 sets,
the training set with 199 patients for training, validation set with 30 patients for fine-tuning, and test set with 107
patients for evaluation, and applied data augmentation to all 3 sets. They used 4 different types of inputs which were
generated with different combinations of DWI, apparent diffusion coefficient map (ADC), Ktrans, and T2w for their
study. They achieved AUC of 0.84 with the augmented test test.
Mehrtash et al.26 also used VGGNet inspired 9 convolution layers deep three dimensional (3D) CNNs classifier
to classify 3D PCa lesions vs. non PCa lesions with 32 × 32 × 12 ROI using ADC, high b-value images, and Ktrans
from dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) of ProstateX challenge dataset25. They
separated the data set with 341 patients into training set with 201 patients and test set with 140 patients, and achieved
lesion-level performance of 0.80 AUC on their test set. They applied cross-validation method within the augmented
training set during training. As it will be discussed in Discussion section, the proposed method in this paper is
superior compared to these ROI-based solutions in terms of robustness and applicability in clinical usage since it
foregos the need for manually or automatically generating ROIs.
Slice-level detection algorithms classify each MRI slice into with or without PCa tumors. Ishioka et al.27
performed the slice-level analysis with 316 patients by U-Net28 combined with ResNet. They created non-augmented
training, validation, and test sets and achieved AUC of 0.79 on the test set, which included only 17 individual slices.
The proposed algorithm in this paper performs slice-level detection as well using a much larger sample size with
superior performance compared to that proposed by Ishioka et al.27.
Patient-level algorithms classify patients into with and without PCa. It is generally a challenging task to merge
ROI-based or slice-level results into patient-level results22–24, 26, 27. Wang et al.29 compared the performance of deep
learning-based methods to non-deep learning-based methods on the classification of PCa MRI slices vs non PCa
MRI slices with 172 patients. They evaluated their VGGNet inspired 7 layers (5 convolution layers and 2 inner
product layers) CNNs classifier’s performance based on cross-validation. First, they classified each slice of a given
patient and then converted the slice-level results into patient-level results by a simple voting strategy and achieved
the patient-level AUC of 0.84, positive prediction value (PPV) of 79%, and negative prediction value (NPV) of 77%.
In this work, we achieved similar results with independent test set and larger sample size.
In this paper, we propose an automated pipeline for two levels of PCa classification: slice-level and patient-level.
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Our pipeline contains five individually trained CNNs architecture that is inspired by ResNet, a decision tree-based
feature extractor, and a Random Forest classifier30, 31. For the robustness of the performance, we divided the dataset
into three separate sets, the training, validation, and test sets, and ensured that the test set was never seen by the
classifier during training and fine-tuning6. Our classifier’s performance on the independent test set was superior and
more robust compared to similar studies that proposed CAD tools for PCa detection using deep CNNs.
Results
The AUC and ROC curve32 were used to evaluate the performance of the proposed pipeline. A ROC curve is a
commonly used method to visualize the performance of a binary classifier by plotting true positive rates and false
positive rates with different thresholds, and an AUC summarizes its performance with a single number. The great
advantage of AUC is its validity in an unbalanced dataset. Since only a small number of DWI slices have PCa tumor
(e.g., average of 1 to 3 slices per patient where the total number of slices are an average of 14), AUC is the best
way to evaluate the performance of the pipeline. In addition, ROC curve allows us to pick desired specificity and/or
sensitivity of the classifier through the threshold. This evaluation method is applied to slice-level and patient-level
classifications using the test set with 108 patients (1,486 slices).
Slice-Level Performance
Since the pipeline contains 5 individually trained CNNs, there are five different test results at slice level. Table 1
shows individual performances on the test set for each CNNs. Our best CNNs (CNN1) achieved the DWI slice-level
AUC of 0.87 (95% Confidence Interval (CI): 0.84−0.90). Figure 1 shows the ROC curve of CNN1 performance.
Architecture Test AUC (95 % CI)
CNN1 0.87 (0.84 - 0.90)
CNN2 0.87 (0.84 - 0.90)
CNN3 0.86 (0.83 - 0.89)
CNN4 0.85 (0.82 - 0.88)
CNN5 0.85 (0.82 - 0.88)
Table 1. Slice-level performances of 5 individually trained deep CNNs.
Figure 1. Slice-level ROC curve of the proposed ResNet inspired deep learning architecture (AUC: 0.87, CI:
0.84−0.90)
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Patient-Level Performance
The patient-level AUC by our Random Forest classifier with the features extracted through CNNs was 0.84 (95% CI:
0.76−0.91) (Figure 2).
Figure 2. Patient-level ROC curve of the proposed pipeline: Random Forest classifier trained on the features
extracted by the CNNs (AUC: 0.84, CI: 0.76−0.91)
Discussion
In the literature, several PCa classification methods for MRI images have been developed to address the inherent
challenges of CAD tools for cancer detection, which can be categorized into two classes: radiomics-driven feature-
based methods9–12, 33, 34 and deep learning-based methods22–24, 26, 27, 29.
Radiomics-driven feature-based methods consist of two stages: extraction of hand crafted features and classifica-
tion based on these features. These methods require a comprehensive set of radiomic features, which include first-
and second-order statistical features, high-level features such as morphological features9, and voxel-level feature10.
For the classification using radiomic features, several approaches have been proposed. Different machine learning
classifiers6 such as naive Bayesian classifier9, support vector machines33, 34, and Random Forest classifier10 have
been used. However, it has been shown that deep learning methods are superior to radiomics-driven feature-based
methods in classification of PCa29.
ROI is one of commonly used data structures in medical image analysis. Usually delineated by the user, ROIs are
samples within medical images identified for a particular purpose35, which often contain cancer tumors. ROI-based
methods directly compare and only classify regions or bounding boxes that contains tumors over healthy tissues.
ROI-based methods have been used in both radiomics-driven and deep CNNs-based methods for PCa CAD tool
design. In deep CNNs-based methods, Liu et al24, Tsehay et al22, and Le et. al.23 used 2D ROIs of cancer tumors
and Mehrtash et al26 and used 3D ROIs of cancer tumors as their data structures (eg. 32×32×12 ROI).
ROI-based CAD algorithms have several limitations. First, ROI-based algorithms require a time consuming
manually generated (by expert reader) or automatically generated segmentation of ROI as a part of the pipeline to
generate ROI-based dataset. If it is a manually generated segmentation, the application for clinical use is limited
because it ultimately relies on the clinician’s review and expertise and is not fully automated. If, on the other
hand, it is an automatically generated segmentation, the result of classification depends on the performance of
the segmentation algorithm, and inaccuracies from ROI segmentation algorithm can lead to poor PCa detection
performance. Moreover, most of ROI-based methods use sliding windows of pixels as data structures to feed the
CNNs, which makes it a challenging task to achieve an acceptable performance on classification of PCa at patient
level due to the fact that each patient’s MRI data constitutes several hundreds of thousands of windows of pixels.
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Therefore, ROI-based methods22, 24, 26 struggle to merge individual ROI-based results into patient-level classification
and they usually rely on basic merging methods such as simple voting29, which makes it a challenging task to
achieve acceptable performance at patient level.
In this work, instead of feeding ROIs into CNNs, we used automatically center cropped DWI images with the
only user intervention being to indicate the first and last slice that contained prostate gland. This is advantageous
because it does not require generation of ROIs by either hand or segmentation algorithms. Thus, the proposed
pipeline performance is independent of ROI generation method. There are other studies in the literature that proposed
slice-based analysis27, 29, but our slice-level performance (AUC: 0.87) and the sample size of the test set (108 patients
or 1,486 slices), were significantly superior to their performance and sample size. For example, Ishioka et al.27
proposed a slice-level algorithm using 316 patient data for training and validation. The test set was only 17 slices
withe AUC of 0.79. Furthermore, we used the results generated by CNNs as features for classifying PCa at patient
level, which was not the case with these previous works on slice-level algorithms.
Completely isolating test data from training and validation is crucial to measure true performance of a (deep)
machine learning-based classifier. Cross-validation is a well-known method to evaluate the performance of the
classifier29. However, it is only relevant for optimizing or fine-tuning the model because there is a possibility that
cross-validation leads to a model that over-fits. Fine-tuning the classifier based on the performance of the test set
(e.g., adopted in23) makes the test set not independent from the trained and optimized classifier, and hence, the
performance achieved is optimistic and not realistic. The fine-tuning and optimization of the model must be done
through a validation set, which is separate than both training and test sets as adopted in our work in this paper
and those of22, 26, 27. Moreover, the test set should not be augmented (e.g., adopted in24) to keep the robustness
of the results. Due to test data cross-contamination with training or validation sets via cross-validation or data
augmentation, the performance of the proposed models in the literature is rather optimistic(e.g.,23, 24).
In this work, we divided the entire dataset into three different sets, training, validation, and test set. In the
slice-level analysis, the training set was used to train the model, and the validation set was used to fine-tune
and optimize our CNNs architecture, and the test set was used to evaluate the performance of the CNNs. In the
patient-level analysis, cross validation was used within the validation set to fine tune and optimize our decision tree
based feature selector and Random Forest classifier, and tested on the test set. As a result, our classifier’s results
were more robust compared to studies that used cross-validation as a measure of the performance29 and training
deep learning classifier without the validation set23. For the studies that used independent test set24, 26, 27, our results
are superior. For example, Liu et al24 conducted 2D ROI slice level analysis and achieved 0.84 AUC for ROC-based
(centered around biopsy location) classification only compared to 0.87 AUC for our proposed pipeline for slice-level
classification.
Turning ROI-level results or the slice-level results of MRI data into patient-level result has been a major challenge
in PCa classification via deep learning22–24, 26, 27. This is due to the fact that the 3D MRI volume of each patient may
have hundreds or thousands of ROIs. Wang et. al.29 converted their slice-level result into patient-level by averaging
all of the slice-level probabilities for patient and thresholding the average probabilities to classify PCa at patient
level. Although this method achieved patient-level performance similar to our proposed pipeline’s results (AUC:
0.84), it is based on cross validation, which makes it an optimistic result. In contrast, the results presented in this
paper is based on a test set which is completely separate than the training and validation sets. Moreover, our test data
contained 108 patients, which is significantly larger than the dataset with 17 patients for each fold29 .
Methods
Data
This retrospective study was approved by the Research Ethics Board (REB) of Sunnybrook Health Sciences Centre
and all methods were carried out in accordance with relevant guidelines and regulations. The need for written
informed consent was waived by the institutional REB. A cohort of 427 consecutive patients with a Pi-Rads score
of 3 or higher who underwent biopsy were included. Out of 427 patients, 175 patients had clinically significant
prostate cancer and 252 patients did not. A total of 5,832 2D slices of each DWI sequence (e.g., b0) which contained
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prostate gland were used as our dataset. We set the patient with Gleason score higher than or equal to 7 (International
Society of Uropatholgists grade group (GG>=2) as the patient with a clinically significant prostate cancer and patient
with Gleason score lower than or equal to 6 (GG=1) or with no cancer (GG=0) as the patient without a clinically
significant prostate cancer.
MRI Acquisition
The DWI data was acquired between January 2014 to July 2017 using a Philips Achieva 3T whole body unit MR
imaging scanner. The transverse plane of DWI sequences was obtained using a single-slot spin-echo echo-planar
imaging sequence with four b values (0, 100, 400, and 1000s mm−2), repetition time (TR) 5000 ∼ 7000ms, echo
time (TE) 61ms, slice thickness 3mm, field of view (FOV) 240mm × 240mm and matrix of 140 × 140.
DWI is an MRI sequence which measures the sensitivity of tissue to Brownian motion and it has been found to
be a promising imaging technique for PCa detection36. The DWI image is usually generated with different b values
(0, 100, 400, and 1000s mm−2) which generates various signal intensities representing the amount of water diffusion
in the tissue and can be used to estimate ADC and compute high b-value images (b1600)37 .
In order to use DWI images as input to our deep learning network, we resized all of the DWI slices into 144
× 144 pixels, and center cropped them with 66 × 66 pixels such that the prostate was covered. The CNNs were
modified to feed DWI data with 6 channels (ADC, b0, b100, b400, b1000, and b1600) instead of images with 3
channels (red, green and blue.)
Training, Validation, and Test sets
We separated 427 patients DWI images into three different sets, the training set with 271 patients (3,692 slices),
the validation set with 48 patients (654 slices), and the test set with 108 patients (1486 slices) where the train-
ing/validation/test ratio was 64%, 11%, 25%. The separation procedure of the dataset was as follows. First, we
separated the dataset into two sets, the training/validation set as 75% and the test set as 25% to maintain a reasonable
sample size for the test set. Second, we separated the training/validation set into two sets with training set as 85% of
training/validation set and the validation set as 15% of training/validation set (Table 2). The ratios between the PCa
patients and non PCa patients are kept roughly similar through out data sets.
Data Set Patients with PCa Patients without PCa Slices with PCa tumors Slices without PCa tumors
Training Set 105 166 439 3,253
Validation Set 18 30 66 588
Test Set 52 56 226 1,260
Table 2. Number of patients and slices with and without PCa for training, validation, and test sets.
Data Preprocessing
All of DWI images in the dataset were normalized using the following function.
Xi_normalized =
Xi−µ
std
(1)
where Xi is the pixels in an individual MRI slice, µ is the mean of the dataset, std is the standard deviation of the
dataset, and Xi_normalized is the normalized individual MRI slice. Normalization was performed across the entire
dataset.
Pipeline
The proposed pipeline consists of three stages. In the first stage, each DWI slice is classified using five individually
trained CNNs models. In the second stage, first-order statistical features (e.g., mean, standard deviation, median,
etc.) are extracted from the probability sets of CNNs outputs, and important features are selected through a decision
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tree-based feature selector. In the last stage, a Random Forest classifier is used to classify patients into groups with
and without PCa using these first order statistical features. The Random Forest classifier was trained and fine-tuned
by the features extracted from the validation set with 10 fold cross-validation method. Figure 3 shows the block
diagram of the proposed pipeline.
Figure 3. The proposed pipeline block diagram. The inputs to each CNNs are 66 × 66 × 6 (ADC, b0, b100, b400,
b1000, b1600) MRI slices. The output is the slice level and patient level results.
ResNet
Since ResNet architecture has shown promising performance in multiple computer vision tasks17, we chose it as
our base architecture for this research. Each Residual Block consists of convolutional layers21 and identity shortcut
connection17 that skips those layers, and their outcomes are added at the end, as shown in Figure 4-Left. When input
and output dimensions are the same, the identity shortcuts, denoted by x, can be directly applied. The following
formula shows the identity mapping process.
y = F(x,{Wi})+ x (2)
where F(x,Wi) is the output from convolutional layers and x is the input. When the dimension of input is not the
same as that of the output (e.g., at the end of the Res. block), the linear projection Ws changes the dimension of the
input to be same as that of the output which is defined as:
Y = F(x,{Wi})+Wsx. (3)
To improve the performance of the architecture, we implemented a fully pre-activated residual network38. In
the original ResNet, batch normalization and ReLU activation layers were followed after the convolution layer,
but in pre-activation ResNet, batch normalization and ReLU activation layers comes before the convolution layers.
The advantage of this structure is that the gradient of a layer does not vanish even when the weights are arbitrarily
small38. Instead of 2-layer deep ResNet block, we implemented a 3-layer deep "bottleneck" building block since it
significantly reduces training time without sacrificing the performance17 (Figure 4-Right).
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Figure 4. The structural difference between original residual network and fully pre-activated residual network.
CNNs Architectures and Training
A ResNet with 41 layers deep was created for the slice-level classification. The architecture is composed of 2D
convolutional layers with a 7×7 filter followed by a 3×3 Max pooling layer and residual blocks (Res Block). The
depth of 41 layers were found to be optimal through hyper-parameter fine-tuning procedure using the validation set.
Since the input images were small (66 × 66 pixels ) and the tumorous regions were even smaller (e.g., 4 × 3 pixels),
additional ResNet blocks or deeper networks were needed. The first ResNet Block (ResNet Block1 in Table 3) is
3-layer bottleneck blocks with 2D CNN layers with filter sizes 64, 64 and 256 which is stacked 4 times. The second
ResNet Block (ResNet Block2 in Table 3) is 3-layer bottleneck blocks with 2D CNN layers with filter sizes 128,
128, and 512 which is stacked 9 times. 2×2 2D Average Pooling, Dropout layer, and 2D Fully connected Layer
with 1000 nodes for two probabilistic outputs are followed by the end of Res Blocks. Table 3 shows the overview of
the proposed CNNs architecture.
Stochastic Gradient Decent39 was used as the optimizer with the initial learning rate of 0.001, and it was reduced
by a factor of 10 when the model stopped improving after iterations. The model was trained with the batch size set
to 8. Dropout rate was set to 0.90. We used a weight decay of 0.000001 and a momentum of 0.90. Since the dataset
is extremely unbalanced, binary cross entropy40 was used as the loss function.
Stacked Generalization
Due to the randomness in training CNNs (for instance, at the beginning of training CNNs, weights are set to arbitrary
random numbers), each CNNs may be different despite identical set of hyper-parameters and input datasets. This
means each CNNs may capture different features for the patient-level classification. Stacked generalization41 is
an ensemble technique that trains multiple classifiers with the same dataset and makes a final prediction using
a combination of individual classifiers’ predictions. Stacked generalization typically yields better classification
performance compared to a single classifier41. We implemented a simple stacked generalization method to improve
the patient-level performance by feeding all the slice-level probabilities generated by the five CNNs into a first-order
statistical feature extractor to generate one set of features for each patient. In the proposed pipeline, the patient-level
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Layer Name Details about the layer
Conv layer 2D Convolutional Layer (7×7, 64, stride 2)
Max Pool 3x3 max pool, stride 2
ResNet Block 1
 1×1,643×3,64
1×1,256
×4
ResNet Block 2
 1×1,1283×3,128
1×1,512
×9
Ave Pool 2D Average Pooling (7×7)
FC Fully Connected Layer (2-d, softmax)
Table 3. The Architecutre of the proposed CNNs
performance significantly improved (2-tailed P = 0.048) using 5 CNNs compared to a single CNNs (AUC: 0.84, CI:
0.76−0.91, vs. AUC: 0.71, CI: 0.61−0.81).
First Order Statistical Feature Extraction
Each CNNs produced two probabilities associated with each class (PCa and non PCa) for each DWI slice. For each
patient using the probability output of each CNNs, top five probabilities for each class of PCa and non PCa that were
above 0.74 were selected. This was done to ensure weak probabilities at slice-level were not used for patient-level
classification. The cutoff of 0.74 was selected by grid-search using the validation set. Next, from the remaining
probabilities for each patient (both PCa and non PCa classes), the first order statistical features were extracted, and
important features were selected by a decision trees-based feature selector. We extracted nine first-order features
which are the mean, standard deviation, variance, median, sum, minimum (only from non PCa class), maximum
(only from PCa class), skewness42, kurtosis42, and range from the minimum to maximum from each probability set.
This produced 90 features for each patient (9 features for PCa and 9 features for non PCa class for each CNNs).
We selected 26 best features using the decision tree-based feature selector43. The decision tree based-feature selector
was fine-tuned and trained with 10 fold cross-validation method using the validation set (Figure 5).
Figure 5. Block diagram of the proposed first-order statistical feature extractor. PCa Set: probabilistic output set
from each CNNs which is associated with PCa class. Non PCa Set: probabilistic output set from each CNNs which
is associated with non PCa class.
Once first-order statistical features were extracted for each patient, a Random Forest classifier 30, 31 was trained
using the validation set and tested on the test set for patient-level classification.
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Computational time
The CNNs were trained using one Nvidia Titan X GPU, 8 cores Intel i7 CPU and 32 GB memory. It took 6 hours to
train all five CNNs with up to 100 iterations, less than 10 seconds to train the Random Forest classifier, and less than
1 minute to test all 108 patients.
LIST OF ABBREVIATIONS
CAD: computer aided detection
DWI: diffusion-weighted magnetic resonance imaging
CNNs: convolutional neural networks
PCa: clinically signification prostate cancer
ResNet: Residual Network
PSA: prostate-specific antigen
DRE: digital rectal exam
TRUS: trans-rectal ultrasound
MRI: magnetic resonance imaging
ROC: receiver operating characteristic curve
ML: machine learning
AI: artificial intelligent
SVM: support vector machine
AUC: area under the curve
PPV: positive prediction value
NPV: negative prediction value
2D: two dimensional
3D: three dimensional
CI: confidence interval
ROI: user drawn region of interest
TR: repetition time
TE: echo time
FOV: field of view
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